International Vaccine Access Center (IVAC)
The International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health accelerates equitable access to vaccines through the generation, synthesis, and use of evidence to inform decision-making and action. We generate, synthesize, and interpret evidence that supports informed vaccine policy decisions. We provide technical assistance for policy-making that increases vaccine equity and coverage, bolsters new introduction decisions and processes, optimizes vaccine use, and advances sustainable vaccine financing. We strengthen efforts to enable equitable access to vaccines,amplify political will, and measure impact to ensure program accountability and sustainability.
A Johns Hopkins University affiliate, Jhpiego is a nonprofit global leader in the creation and delivery of transformative healthcare solutions that save lives. Through our close partnerships with local communities, policymakers, donors and health providers, we are able to transform health care systems, leading to better health across a lifespan—from pregnancy to delivery, and beyond. By embedding our know-how and skills into everyday practice, we are creating lasting change that improves the health of some of the world’s most disadvantaged for generations to come. During the pandemic, Jhpiego has partnered with the 30+ countries where we work to prevent, identify and respond to COVID-19, safely deliver care and maintain essential, lifesaving health services for women, men and their families.
The University of Antwerp
The University of Antwerp is a young, dynamic and forward-thinking university. It integrates the assets of its historical roots with its ambition to contribute positively to society, provides access to and disseminates scientific knowledge through research, teaching and academic service to the community and accomplishes these tasks in a spirit of academic freedom and responsibility.
The Centre for Evaluation of Vaccination (CEV) at the University of Antwerp has served as the secretariat for the Viral Hepatitis Prevention and Control Board (VHPB) since 1991, and the HPV Prevention Control Board (HPV Board) since 2015. In over 70 meetings since 1991 and 2015, these boards pioneered a unique approach for helping countries, regions, and international partners introduce Hepatitis B and HPV vaccines into their National Immunization Programs. The VHPB and HPV Prevention Boards have focused on touching the ground; focusing on the real-world issues, problems and successes faced by immunization managers, decision makers, partners in academia, partner agencies, and civil society.
The London School of Hygiene and Tropical Medicine (LSHTM)
The London School of Hygiene & Tropical Medicine (LSHTM) is renowned for its world-leading research, postgraduate studies, and continuing education in public and global health. LSHTM has 3,300 staff based all around the world, with core hubs in London and with additional sites in The Gambia and Uganda. Researchers at LSHTM explore all aspects of health challenges, from fundamental laboratory science to policy appraisal and analysis, encompassing statistical, clinical, laboratory, epidemiological and social science research in the UK and globally. LSHTM is involved at every stage of the research pipeline, from basic science to evaluation of health interventions.
The Vaccine Confidence Project (VCP) at The London School of Hygiene & Tropical Medicine monitors public confidence in immunisation programmes by building information surveillance systems for early detection of public concerns around vaccines; by applying diagnostic data tools to collected data to determine the risk level of public concerns in terms of their potential to disrupt vaccine programmes; and to provide analysis and guidance or early response and engagement with the public to ensure sustained confidence in vaccines and immunisation. This initiative also defines a Vaccine Confidence Index as a tool for mapping confidence globally. The VCP has extensive experience in investigating the root causes of challenges with vaccine confidence in various contexts, including around HPV vaccination in countries around the world.